ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: Maturity Onset Diabetes of the Young Type III
Gene/Gene Panel: HNF1A
Context: Adult
Date
Status
Outcomes-Interventions
Notes
2024/03/24
Released
2.0.1
Diabetes-related morbidity and mortality (GroupB)
Evaluation by specialist to guide management, including with sulfonylureas (GroupB) 8ND
Diabetes-related morbidity and mortality (GroupA)
Evaluation by specialist to guide management, including with sulfonylureas (GroupA) 10ND
System migration to fix the sem versioning
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
HNF4A 0007452 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
Moderate Actionability
Moderate Actionability
2024/03/24
Released (Under revision)
NaN.0.0
Diabetes-related morbidity and mortality (GroupB)
Evaluation by specialist to guide management, including with sulfonylureas (GroupB) 8ND
Diabetes-related morbidity and mortality (GroupA)
Evaluation by specialist to guide management, including with sulfonylureas (GroupA) 10ND
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
HNF4A 0007452 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
Moderate Actionability
Moderate Actionability
2023/04/20
Released
NaN.0.0
Diabetes-related morbidity and mortality (GroupB)
Evaluation by specialist to guide management, including with sulfonylureas (GroupB) 8ND
Diabetes-related morbidity and mortality (GroupA)
Evaluation by specialist to guide management, including with sulfonylureas (GroupA) 10ND
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
HNF4A 0007452 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
Moderate Actionability
Moderate Actionability
2023/03/07
Released (Under revision)
..NaN
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
2022/06/21
Released
..NaN
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
2022/06/21
Released (Under revision)
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
2022/06/20
Released
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
HNF1A 0010894 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
Strong Actionability
Strong Actionability
2022/05/10
Released (Under revision)
1.2.2
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Internal system migration associated with MONDO name addition.
2022/02/09
Released
1.2.2
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Internal system migration associated with MONDO name addition.
2022/02/09
Released (Under revision)
1.2.1
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
2020/04/27
Released
1.2.1
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
2020/04/27
Released (Under revision)
1.2.0
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.2.0
Suboptimal glycemic control (GroupA)
Sulfonylureas/ optimal diabetic control (GroupA) 11CC
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/04/04
Released
1.1.0
Suboptimal glycemic control
Sulfonylureas/ optimal diabetic control 11CC
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.3
Suboptimal glycemic control
Sulfonylureas/ optimal diabetic control 11CC
Internal system migration related to score text replacement from E to N
2018/03/21
Released
1.0.2
Suboptimal glycemic control
Sulfonylureas/ optimal diabetic control 11CC
2018/03/21
Released (Under revision)
1.0.1
Glycemic control
Sulfonylureas/ optimal diabetic control 11CC
2018/01/11
Released
1.0.1
Glycemic control
Sulfonylureas/ optimal diabetic control 11CC
2017/10/31
Released
1.0.0
Glycemic control
Sulfonylureas/ optimal diabetic control 11CC
¤ Powered by BCM's Genboree.